Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra.
D000230:Adenocarcinoma / Q000276:immunology* / Q000628:therapy; D000328:Adult; D000368:Aged; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D002295:Carcinoma, Transitional Cell / Q000276:immunology* / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000276:immunology; D011379:Prognosis; D012008:Recurrence; D013997:Time Factors; D014523:Urethral Neoplasms / Q000276:immunology* / Q000628:therapy; D001749:Urinary Bladder Neoplasms / Q000276:immunology* / Q000628:therapy
D002272:Carcinoembryonic Antigen